mast cell leukemia

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial

Completed
  • Aggressive Systemic Mastocytosis
  • +3 more
  • Stanford, California
  • +10 more
Jan 12, 2023

High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,

Terminated
  • High-risk Myelodysplastic Syndromes
  • +3 more
  • GTB-3550 TriKE® Phase I
  • GTB-3550 TriKE® Phase II
  • Minneapolis, Minnesota
  • +1 more
Mar 21, 2022

Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor

Active, not recruiting
  • Advanced Systemic Mastocytosis
  • +3 more
  • Stanford, California
  • +31 more
Mar 25, 2022

Avapritinib Versus Best Available Therapy in Patients With AdvSM

Completed
  • Advanced Systemic Mastocytosis
  • +3 more
    • Palo Alto, California
    • +5 more
    Dec 17, 2021

    Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematological Tumor

    Approved for marketing
    • Advanced Systemic Mastocytosis
    • +3 more
    • (no location specified)
    Oct 5, 2021

    Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With

    Completed
    • Acute Undifferentiated Leukemia
    • +10 more
    • bioelectric impedance analysis
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Jul 30, 2020

    Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in

    Completed
    • Acute Undifferentiated Leukemia
    • +63 more
    • total-body irradiation
    • +7 more
    • Seattle, Washington
    • +1 more
    Jan 17, 2020

    Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic

    Completed
    • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
    • +76 more
    • fludarabine phosphate
    • +6 more
    • Tucson, Arizona
    • +10 more
    Jan 17, 2020

    Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis Trial in Stanford, Houston (Brentuximab vedotin)

    Completed
    • Aggressive Systemic Mastocytosis
    • +2 more
    • Brentuximab vedotin
    • Stanford, California
    • +1 more
    Jan 9, 2019

    Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis Trial in Stanford (Ibrutinib)

    Terminated
    • Aggressive Systemic Mastocytosis
    • +2 more
    • Stanford, California
      Stanford University Hospitals and Clinics
    Aug 24, 2018

    Collecting and Storing Malignant, Borderline Malignant

    Completed
    • Acute Undifferentiated Leukemia
    • +13 more
    • Cytology Specimen Collection Procedure
    • Birmingham, Alabama
    • +191 more
    Jul 17, 2018

    Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +178 more
    • fludarabine phosphate
    • +5 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Apr 17, 2017

    Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +50 more
    • Akt inhibitor MK2206
    • +2 more
    • Birmingham, Alabama
    • +24 more
    Apr 28, 2014

    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +84 more
    • sunitinib malate
    • +2 more
    • Los Angeles, California
    • +10 more
    Mar 14, 2014